EurekAlert! -
23 Dec 2013 07:00
(GYMR) The Alzheimer's Prevention Initiative trial in cognitively healthy individuals has reached a significant milestone with the first participants in Colombia receiving doses of an experimental anti-amyloid antibody, crenezumab designed to delay or prevent the onset of Alzheimer's disease.
Share this Article